Evidence map›Paper›PMID 28140487›Full record

ArticleAngewandte Chemie (International ed. in English)2017

Mccrearamycins A-D, Geldanamycin-Derived Cyclopentenone Macrolactams from an Eastern Kentucky Abandoned Coal Mine Microbe.

Xiachang Wang, Yinan Zhang, Larissa V Ponomareva, Qingchao Qiu, Ryan Woodcock, Sherif I Elshahawi, Xiabin Chen, Ziyuan Zhou, Bruce E Hatcher, James C Hower and 6 more

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Chemical genetics of regeneration: Contrasting temporal effects of CoClDevelopmental dynamics : an official publication of the American Association of Anatomists · 2021
    Article
  8. Metabolites · 2020
    Article
  9. Article
  10. Article
  11. OleD Loki as a Catalyst for Hydroxamate Glycosylation.Chembiochem : a European journal of chemical biology · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Xiachang WangCenter for Pharmaceutical Research and Innovation, College of Pharmacy, University of Kentucky, Lexington, Kentucky, 40536, USA.ORCID 0000-0002-1106-1904
Yinan ZhangCenter for Pharmaceutical Research and Innovation, College of Pharmacy, University of Kentucky, Lexington, Kentucky, 40536, USA.
Larissa V PonomarevaCenter for Pharmaceutical Research and Innovation, College of Pharmacy, University of Kentucky, Lexington, Kentucky, 40536, USA.
Qingchao QiuDepartment of Biology, University of Kentucky, Lexington, KY, 40506, USA.
Ryan WoodcockDepartment of Biology, University of Kentucky, Lexington, KY, 40506, USA.
Sherif I ElshahawiCenter for Pharmaceutical Research and Innovation, College of Pharmacy, University of Kentucky, Lexington, Kentucky, 40536, USA.ORCID 0000-0003-1879-1552
Xiabin ChenCenter for Pharmaceutical Research and Innovation, College of Pharmacy, University of Kentucky, Lexington, Kentucky, 40536, USA.
Ziyuan ZhouCenter for Pharmaceutical Research and Innovation, College of Pharmacy, University of Kentucky, Lexington, Kentucky, 40536, USA.
Bruce E HatcherKentucky Division of Abandoned Mine Lands, 300 Sower Blvd, Frankfort, KY, 40601, USA.
James C HowerCenter for Applied Energy Research, University of Kentucky, Lexington, KY, 40511, USA.ORCID 0000-0003-4694-2776
Chang-Guo ZhanCenter for Pharmaceutical Research and Innovation, College of Pharmacy, University of Kentucky, Lexington, Kentucky, 40536, USA.
Sean ParkinDepartment of Chemistry, University of Kentucky, Lexington, KY, 40506, USA.
Madan K KharelSchool of Pharmacy, University of Maryland Eastern Shore, Princess Anne, Maryland, 21853, USA.
S Randal VossDepartment of Biology, University of Kentucky, Lexington, KY, 40506, USA.
Khaled A ShaabanCenter for Pharmaceutical Research and Innovation, College of Pharmacy, University of Kentucky, Lexington, Kentucky, 40536, USA.
Jon S ThorsonCenter for Pharmaceutical Research and Innovation, College of Pharmacy, University of Kentucky, Lexington, Kentucky, 40536, USA.ORCID 0000-0002-7148-0721
University of Kentucky · USKentucky Department of Education · USUniversity of Maryland Eastern Shore · US

Funding

Kentucky Center for Clinical and Translational ScienceUL1TR001998 · NCATS · UNIVERSITY OF KENTUCKY · PI HARTMANN, KATHERINE E, KERN, PHILIP A · 2016 to 2025
$34.2M
Kentucky Center for Clinical and Translational ScienceUL1TR000117 · NCATS · UNIVERSITY OF KENTUCKY · PI KERN, PHILIP A · 2012 to 2015
$13.3M
Training in Drug Abuse Related Research.T32DA016176 · NIDA · UNIVERSITY OF KENTUCKY · PI DWOSKIN, LINDA P · 2004 to 2020
$4.0M
Developing Regeneration Resources for a Model AmphibianR24OD021479 · OD · UNIVERSITY OF KENTUCKY · PI THORSON, JON SCOTT, VOSS, STEPHEN RANDAL · 2016 to 2019
$2.3M
NCATS NIH HHS UL1 TR000117NCATS NIH HHS UL1 TR001998NIDA NIH HHS T32 DA016176NIH HHS R24 OD021479
6 · The paper itself

Abstract

Four cyclopentenone-containing ansamycin polyketides (mccrearamycins A-D), and six new geldanamycins (Gdms B-G, including new linear and mycothiol conjugates), were characterized as metabolites of Streptomyces sp. AD-23-14 isolated from the Rock Creek underground coal mine acid drainage site. Biomimetic chemical conversion studies using both simple synthetic models and Gdm D confirmed that the mccrearamycin cyclopentenone derives from benzilic acid rearrangement of 19-hydroxy Gdm, and thereby provides a new synthetic derivatization strategy and implicates a potential unique biocatalyst in mccrearamycin cyclopentenone formation. In addition to standard Hsp90α binding and cell line cytotoxicity assays, this study also highlights the first assessment of Hsp90α modulators in a new axolotl embryo tail regeneration (ETR) assay as a potential new whole animal assay for Hsp90 modulator discovery.

Indexed as

Cell Line, TumorCell SurvivalCoalCyclopentanesHSP90 Heat-Shock ProteinsHumansKentuckyLactams, MacrocyclicMolecular ConformationStereoisomerismStreptomycesCoalCyclopentanescyclopentenoneHSP90AA2P protein, humanHSP90 Heat-Shock ProteinsLactams, Macrocyclicansamycinaxolotlbiomimetic synthesisHsp90regeneration

Identifiers

PMID28140487
PMCPMC5339036
OpenAlexW2584457127

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.